衢州东峰：预计2025年度净利润为-5.8亿元至-4.3亿元

Group 1 - The company expects a net profit attributable to shareholders for the year 2025 to be between -580 million and -430 million yuan, indicating a loss [1] - The primary reasons for the performance change include the economic downturn, implementation of drug procurement policies, and downstream customers digesting previous inventory [1] - The company conducted an impairment test on goodwill related to acquisitions of several pharmaceutical packaging companies, and the final impairment amount will be determined after evaluation and audit by appointed institutions [1]